Atacama Resources International, Inc. (ACRL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 FY14: 0 FY15: 0 FY16: 0 FY14 FY15 FY16

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-900K -600K -300K 0 300K 600K 900K FY15: -254.5K FY16: -833.2K FY15 FY16

Net Income Annual

-1.8M -1.2M -600K 0 600K 1.2M 1.8M FY13: -155K FY14: -782.4K FY15: -282.9K FY16: -1.5M FY13 FY14 FY15 FY16

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-1.1M -700K -350K 0 350K 700K 1.1M FY13: -16.3K FY14: -7K FY15: -97.7K FY16: -882.4K FY13 FY14 FY15 FY16

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

0 20M 40M 60M FY14: 31.5M FY15: 57.2M FY14 FY15

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q4 '14: -0.01 Q1 '15: -0.01 Q2 '15: -0.01 Q3 '15: -0.01 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.01 Q1 '17: -0.01 Q2 '17: -0.01 Q3 '17: -0.06 Q1 '15 Q3 '15 Q1 '16 Q3 '16 Q1 '17 Q3 '17

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.